Fundraising FoxSilvergate Pharmaceuticals
Greenwood Village, US · Founded 2010 · Delaware corporation · 1 known investors
Find your way into Silvergate Pharmaceuticals
Sign up to see every warm intro you have to Silvergate Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Silvergate Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
FS
Frank SegravePresident
BB
Barry BarnardChief Financial Officer
Board
PH
NE
BC
Bhaskar ChauduriBoard director
BC
Bhaskar ChaundhuriBoard director
MP
Mark ParrishBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.2M disclosed across 3 rounds · 2014–2016
▶$4.6MraisedOct 2016 · 10 investors · PharmaceuticalsRule 506(b)
▶$4.6MraisedOct 2016 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bhaskar ChaundhuriDirector
- Barry BarnardExecutive Officer
- Laura MedinaExecutive Officer
- Frank SegraveExecutive Officer, Director
- Robert MauroExecutive Officer
- Mark ParrishDirector
- Patrick HeronDirector
- Nathan EveryDirector
- Michael BeckloffExecutive Officer
- Offering amount
- $4.6M
- Amount sold
- $4.6M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedOct 2015 · 9 investors · PharmaceuticalsRule 506(b)
▶$1.6MraisedOct 2015 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Frank SegraveExecutive Officer, Director
- Michael BeckloffExecutive Officer
- Robert MauroExecutive Officer
- Patrick HeronDirector
- Bhaskar ChaundhuriDirector
- Nathan EveryDirector
- Barry BarnardExecutive Officer
- Mark ParrishDirector
- Offering amount
- $4.6M
- Amount sold
- $1.6M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedSep 2014 · 7 investors · PharmaceuticalsRule 506(b)
▶$1MraisedSep 2014 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Nathan EveryDirector
- Frank SegraveExecutive Officer, Director
- Mark ParrishExecutive Officer, Director
- Bhaskar ChauduriDirector
- Patrick HeronDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Silvergate Pharmaceuticals's investors?
- Silvergate Pharmaceuticals's investors include Frazier Life Sciences.
- How much funding has Silvergate Pharmaceuticals raised?
- Silvergate Pharmaceuticals has disclosed $7.2M raised across 3 rounds.
- Where is Silvergate Pharmaceuticals headquartered?
- Silvergate Pharmaceuticals is headquartered in Greenwood Village, US.